Home Tags Cancer-drug

Tag: cancer-drug

wwwblockcastcc

A most cancers-drug developer’s stock factual surged more than 100% after Merck agreed to...

0
picture alliance/Getty ImagesShares of the cancer-drug developer ArQule skyrocketed as much as 102% early Monday after Merck agreed to acquire the company in a $2.7 billion takeover. Merck offered $20 per share in the all-cash bid, more than double ArQule's Friday closing price of $9.66. ArQule's lead drug candidate, ARQ 531, is in phase-two testing…